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Abstract: Nanoparticles (NPs) are tiny materials used in a wide range of industrial and 
medical applications. Titanium dioxide (TiO2) is a type of nanoparticle that is widely used 
in paints, pigments, and cosmetics; however, little is known about the impact of TiO2 on 
human health and the environment. Therefore, considerable research has focused on 
characterizing the potential toxicity of nanoparticles such as TiO2 and on understanding the 
mechanism of TiO2 NP-induced nanotoxicity through the evaluation of biomarkers. 
Uncoated TiO2 NPs tend to aggregate in aqueous media, and these aggregates decrease cell 
viability and induce expression of stress-related genes, such as those encoding interleukin-6 
(IL-6) and heat shock protein 70B’ (HSP70B’), indicating that TiO2 NPs induce 
inflammatory and heat shock responses. In order to reduce their toxicity, we conjugated 
TiO2 NPs with polyethylene glycol (PEG) to eliminate aggregation. Our findings indicate 
that modifying TiO2 NPs with PEG reduces their cytotoxicity and reduces the induction of 
stress-related genes. Our results also suggest that TiO2 NP-induced effects on cytotoxicity 
and gene expression vary depending upon the cell type and surface modification. 
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1. Introduction 
Nanoparticles (NPs) are tiny materials (diameter of 1 to 100 nm in at least one dimension) [1] 
characterized by a very high surface area-to-volume ratio [2]. Due to the unique properties afforded by 
their size, NPs possess a wide range of applications in the industrial, electrical, agricultural, 
pharmaceutical, and medical fields. However, despite the wide application of nanomaterials, little is 
known about their impact on human health and the environment. As a result, considerable effort has 
been expended on identifying the potential toxicity of NPs to cells and organisms. It has been 
suggested that the small size and corresponding high specific surface area are the major determinants 
of NP toxicity [3]. It has also been proposed that the surface area of NPs greatly increases their ability 
to produce potentially toxic reactive oxygen species (ROS) [4]. 
Titanium dioxide (TiO2), which is used as a photocatalyst [5] in air and water cleaning and is found 
in a wide array of products including paints, pigments, cosmetics, and skin care products [6], has been 
classified as a biologically inert substance with respect to both animals and humans [7,8]. TiO2 NPs 
can be applied in biomedical fields, for example, TiO2 NPs could be used for sonodynamic therapy for 
cancer [9]. However, recent investigations revealed that rats exposed to ultra fine TiO2 (UF-TiO2) NPs 
develop inflammation, pulmonary damage, and lung tumors [10,11]. This toxicity may be due to the 
ease with which these NPs can pass through the cell membrane and disrupt biological systems [12]. 
The design and evaluation of proper safety measures for NPs thus necessitates a more complete 
understanding of how nanomaterials interact with cells. 
Polyethylene glycol (PEG) is a coiled polymer of repeating ethylene ether units with a dynamic 
conformation. PEG is inexpensive, versatile, and FDA-approved for many applications [13]. In 
addition, PEG is non-toxic and non-immunogenic, and has favorable pharmacokinetics and tissue 
distribution [14]. Modifying the surface of NPs with PEG (PEGylation) not only prevents 
agglomeration [15], but also renders NPs resistant to protein adsorption and enhances their 
biocompatibility [16]. Coating nanomaterials with PEG also increases the in vivo circulation time, 
thereby likely reducing clearance via the reticuloendothelial system (RES) [17]. PEGylated single 
walled carbon nanotubes exhibited less cytotoxic potency than uncoated ones [18]. 
Studies of the effects of TiO2 NPs in rodent lungs have shown that NPs induce elevated expression 
of proinflammatory factors such as interleukins 1 (IL-1) and 6 (IL-6), tumor necrosis factor-α (TNF-α), 
macrophage inhibitory protein, and monocyte chemotactic protein [19]. In our previous study [20], we 
examined the cytotoxicity of two types of TiO2 NP aggregates: small-TiO2 NPs (166 nm) and   
large-TiO2 NPs (596 nm). Cytotoxicity and mRNA expression analyses indicated that large-TiO2 NP 
aggregates have a greater effect on cell viability and the expression of molecular marker genes, such as 
heat shock protein (HSP) and IL-6, than do the small-TiO2 aggregates using NCI-H292 and THP-1 
cells. We also developed a sensor cell for evaluating nanomaterial biosafety that assesses NF-κB 
pathway activation to detect TiO2 NP-induced inflammation [21].  Int. J. Mol. Sci. 2012, 13                 
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Here, we report the results of experiments aimed at reducing the cytotoxicity and induction of gene 
expression associated with TiO2 NP exposure by modifying the surface of TiO2 NPs with PEG. This 
study focused on the effects of PEG-conjugated TiO2 (PEG-TiO2-49.6 nm) at the cellular and gene 
expression levels. We conducted cell viability testing and mRNA expression analysis in different cell 
lines to assess how PEG modification affects stress and toxicity. Our results indicate that modification 
of TiO2 NPs with PEG reduces both their cytotoxicity and the induction of toxicity marker   
gene expression. 
2. Results and Discussion 
2.1. Viability of Cells Exposed to PEG-TiO2 NPs 
In our previous study, we demonstrated the effects of exposure to TiO2 NP aggregates on cell 
viability using two different human cell lines [20]. The results indicated that high concentrations of 
TiO2 NP aggregates have a negative impact on cell viability. NCI-H292 cells exposed to 20 µg/mL of 
TiO2 NP aggregates showed about 80% viability [20]. In this study, we focused on the effects of  
PEG-TiO2 NPs, which we predicted would be less toxic and induce less expression of genes associated 
with stress and toxicity. Since it is not clear how NPs affect different cell types, we utilized four 
different human cell lines in this study. 
To analyze the cellular effects of PEG-TiO2, different cell lines (NCI-H292, THP-1, HeLa and 
HepG2) were exposed to NPs. Cells with no exposure to NPs were also tested as controls for those cell 
lines. To determine the effect of PEG-TiO2 NP exposure on cell viability, the concentration of 
cytoplasmic ATP (which signals the presence of metabolically active cells) was determined after 24 h 
of exposure. At a high concentration of PEG-TiO2 NPs, the viability of both NCI-H292 and THP-1 
cells decreased slightly to 95% (Figures 1 and 2, respectively). There was no apparent change in the 
viability of HeLa and HepG2 cells after 24 h of exposure to PEG-TiO2 NPs (Figures 3 and 4). In a 
similar experiment involving 6 h of exposure to PEG-TiO2 NPs, all cell lines maintained 100% 
viability (data not shown). Our findings thus indicate that modification of TiO2 NPs with PEG reduces 
the cytotoxicity of the particles. In addition, our data indicate that the cytotoxicity of PEG-TiO2 NPs 
differs between cell lines. 
Figure 1. Cell viability testing based on cytoplasmic ATP concentration. NCI-H292 cells 
were exposed to the indicated concentrations of PEG-TiO2 NPs for 24 h. Results are shown 
as the mean ± SD, n ≥ 3 for each concentration. * P < 0.01. 
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Figure 2. Cell viability testing based on cytoplasmic ATP concentration. THP-1 cells were 
exposed to the indicated concentrations of PEG-TiO2 NPs for 24 h. Results are shown as 
the mean ± SD, n ≥ 3 for each concentration. 
 
Figure 3. Cell viability testing based on cytoplasmic ATP concentration. HeLa cells were 
exposed to the indicated concentrations of PEG-TiO2 NPs for 24 h. Results are shown as 
the mean ± SD, n ≥ 3 for each concentration. 
 
Figure 4. Cell viability testing based on cytoplasmic ATP concentration. HepG2 cells were 
exposed to the indicated concentrations of PEG-TiO2 NPs for 24 h. Results are shown as 
the mean ± SD, n ≥ 3 for each concentration. 
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2.2. mRNA Expression Analysis of NP-Exposed Cells 
To identify potential biomarkers of nanoparticle toxicity, we conducted a Human Stress and 
Toxicity Pathway Finder PCR array analysis of 84 genes indicative of stress and toxicity, using   
NCI-H292 cells exposed to PEG-TiO2 NPs for 6 h. Genes selected as biomarker candidates based on 
the PCR array results included CCNG1, CRYAB, CSF-2, CYP2E1, CYP7A1, FMO1, FMO5, 
GSTM3, HMOX-1, HSPA6, IL-6, LTA, TNF, and UGT1A4 (Table 1). 
Table 1. Lists for genes showed induction of mRNA expression in PEG-TiO2  
particles-exposed NCI-H292 cells after 6 h in PCR array. 
Symbols of Genes  Description of the Genes 
CCNG1 Cyclin  G1 
CRYAB  Crystallin, alpha B 
CSF2  Colony stimulating factor 2 (granulocyte- macrophage) 
CYP2E1  Cytochrome P450, family 2, subfamily E, polypeptide 1 
CYP7A1  Cytochrome P450, family 7, subfamily A, polypeptide 1 
FMO1  Flavin containing monooxygenase 1 
FMO5  Flavin containing monooxygenase 5 
GSTM3  Glutathione transferase M3  
HMOX1  Heme oxygenase 1 
HSPA6  Heat Shock 70kDa protein 6 (HSP70B’) 
IL6  Interleukin 6 (interferon, beta 2) 
LTA  Lymphotoxin alpha (TNF superfamily, member 1) 
TNF  Tumor necrosis factor (TNF superfamily, member 2) 
UGT1A4  UDP glucuronosyltransferase 1 family, polypeptide A4 
We next investigated the level of mRNA expression of stress- and toxicity-associated molecular 
markers in PEG-TiO2 NP-exposed cells using RT-PCR. Selected molecular markers included the 
oxidative marker HMOX-1 and the inflammation markers IL-6 and CSF-2, because expression of 
mRNAs for these markers was statistically higher than the other markers after treatment with   
PEG-TiO2 NPs. In PEG-TiO2 NP-exposed NCI-H292 cells, a significant increase in the level of IL-6 
mRNA was observed after 6 h (Figure 5, solid black bars). The level of HMOX-1 mRNA was also 
significantly increased (2-fold higher than in control cells); however, the level of CSF-2 mRNA was 
lower than that in the control cells after 6 h of exposure. There was no significant difference in the 
level of HMOX-1, IL-6, or CSF-2 mRNA expression when the exposure duration was increased to  
24 h (Figure 5, open bars). Int. J. Mol. Sci. 2012, 13                 
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Figure 5. Expression of stress and toxicity marker mRNAs in PEG-TiO2 NP-exposed   
NCI-H292 cells. Cells were exposed for 6 h (solid black bars) or 24 h (open bars). Results 
are shown as the mean ± SD, n ≥ 3 for each marker. * P < 0.05, ** P < 0.01. 
 
In the case of THP-1 cells, no significant changes in the induction of HMOX-1, IL-6, or CSF-2 
mRNA expression were observed after 6 h (Figure 6, solid black) or 24 h (Figure 6, open bars) of 
exposure to PEG-TiO2 NPs. These results indicate that PEG-TiO2 NPs do not induce expression of 
these molecular markers in THP-1 cells. 
Figure 6. Expression of stress and toxicity marker mRNAs in PEG-TiO2 NP-exposed 
THP-1 cells. Cells were exposed for 6 h (solid black bars) or 24 h (open bars). Results are 
shown as the mean ± SD, n ≥ 3 for each marker. 
 
Similarly, neither 6 h nor 24 h of exposure to PEG-TiO2 NPs resulted in induction of HMOX-1,  
IL-6, or CSF-2 mRNA expression in HeLa cells (Figure 7). In HepG2 cells, 6 h of PEG-TiO2 NP 
exposure resulted in significant induction of CSF-2 mRNA expression compared to control cells 
(Figure 8, solid black bars), and a reduction in IL-6 mRNA expression after 24 h of exposure (Figure 8, 
open bars). The data indicate that each cell line responds differently to PEG-TiO2 NP exposure, which 
suggests that the induction of mRNA expression depends upon both the NPs and the cell type. 
** Int. J. Mol. Sci. 2012, 13                 
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Figure 7. Expression of stress and toxicity marker mRNAs in PEG-TiO2 NP-exposed 
HeLa cells. Cells were exposed for 6 h (solid black bars) or 24 h (open bars). Results are 
shown as the mean ± SD, n ≥ 3 for each marker. 
 
Figure 8. Expression of stress and toxicity marker mRNAs in PEG-TiO2 NP-exposed 
HepG2 cells. Cells were exposed for 6 h (solid black bars) or 24 h (open bars). Results are 
shown as the mean ± SD, n ≥ 3 for each marker. * P < 0.05, ** P < 0.01. 
 
In our previous study, we demonstrated that exposure to high concentrations of TiO2 NP aggregates 
affects the expression of a number of genes [20]. In NCI-H292 cells, expression of the genes encoding 
heat shock protein 70B’ (HSP70B’) and IL-6 increased 100-fold and 10-fold, respectively, upon 
exposure to TiO2 NP aggregates. Exposure to TiO2 NP aggregates resulted in a six-fold increase in 
expression of the IL-6 gene in THP-1 cells [20]. In the present study, no induction of HSP70B’ 
expression upon PEG-TiO2 NP exposure was observed in any of the cell lines examined (data not 
shown). An induction of only approximately 3.5-fold was observed in the NCI-H292 cells exposed to 
PEG-TiO2 NPs. Our results thus indicate that modifying the surface of TiO2 NPs with PEG reduces the 
induction of genes associated with stress and toxicity. 
2.3. Discussion 
Titanium dioxide has a wide range of applications. Uncoated TiO2 NPs, like other insoluble 
nanomaterials, tend to clump together in aqueous media [22]. In our previous study [20], we focused 
** 
* 
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on the effect of TiO2 NP aggregates on cytotoxicity and gene expression. A series of in vivo and  
in vitro studies [23–28] of aggregated TiO2 NPs showed that these particles stimulate the production of 
ROS and induce an inflammatory response that damages the cells and neurons and affects the central 
nervous system. In order to reduce these deleterious biological effects of TiO2 NPs, we conjugated 
TiO2 NPs with PEG to minimize the formation of aggregates. PEG possesses a number of important 
physicochemical and biological properties, including hydrophilicity, solubility in water and organic 
solvents, and lack of toxicity [29,30]. The present study focused primarily on the effects of PEG-TiO2 
NPs in different cell lines. The number of viable NCI-H292 cells decreased slightly upon exposure to 
high concentrations of PEG-TiO2 NPs, indicating that PEG-TiO2 exposure results in a minimal degree 
of stress in these cells. In our previous study, we demonstrated that exposure to large-TiO2 NP 
aggregates reduces the number of viable NCI-H292 cells by around 20%, as compared to exposure to 
small-TiO2 NP aggregates. As demonstrated here, treatment with PEG-TiO2 NPs reduces the number 
of viable NCI-H292 cells by only around 5%, as compared to TiO2 NPs (Figure 1). Our results thus 
indicate that modification with PEG reduces the cytotoxic effects of TiO2 NPs. However, it is difficult 
to distinguish between surface characters and cytotoxic activities, because PEG coated TiO2 NPs 
changed not only surface character, but also particle aggregate size. 
We also performed PCR array analysis of 84 genes that are indicative of stress and toxicity. The 
mRNA expression analysis was performed, based upon the data obtained from the PCR array. PCR 
array is a sensitive technique used to screen for biomarkers related to human stress and toxicity. In our 
experiments, gene expression in response to PEG-TiO2 NP exposure varied with cell type. NCI-H292 
cells responded quickly to PEG-TiO2 NP exposure (6 h) with induction of the proinflammatory 
cytokine IL-6 and oxidative stress marker HMOX-1, and a significant reduction in expression of the 
cytokine CSF-2. However, the pattern of gene expression changed when the duration of NP exposure 
was increased to 24 h, probably because the cells had adapted to the presence of NPs, and therefore did 
not show induction of any of the biomarkers. The same experiment was conducted using THP-1, 
HeLa, and HepG2 cells; however, the response of these cell lines differed from that of the NCI-H292 
cell line. Induction of stress and toxicity biomarkers upon PEG-TiO2 NP exposure was observed only 
in NCI-H292 cells. In HepG2 cells especially, PEG-TiO2 NP reduced proinflammatory cytokine IL-6, 
but induced anti-inflammatory CSF-2. Some studies have shown that increased levels of 
proinflammatory cytokines such as TNF-α, IL-1, and IL-6, coupled with the oxidative stress resulting 
from increased generation of ROS, induces cardiac dysfunction [31,32]. However, another study 
showed that inhalation of TiO2 gives rise to a more pronounced inflammatory response than does 
inhalation of the same mass of larger TiO2 particles [33]. 
One mechanism whereby NPs can be transported into cells is through a process called endocytosis [34]. 
Endocytosis involves multiple processes that fall into two categories: phagocytosis and pinocytosis. 
Phagocytosis is a principal component of the body’s innate immunity in which macrophages 
internalize targets in an actin-dependent manner. Thus, phagocytosis by macrophages is critical for the 
uptake of large particles (0.2–10 µm) [35]. Monocytes/macrophages and neutrophils have been 
described as professional phagocytes [36]. Pinocytosis occurs in all cell types and is mediated by at 
least four basic mechanisms: macropinocytosis, clathrin-mediated endocytosis, caveolae-mediated 
endocytosis, and clathrin-caveolae independent endocytosis [37]. Macropinocytosis is the non-selective 
endocytosis of solute molecules [38], and is associated with the formation of actin-dependent Int. J. Mol. Sci. 2012, 13                 
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membrane ruffles up to 5 µm in diameter [39]. Clathrin-mediated endocytosis is the most important 
mechanism for receptor-mediated endocytosis, and involves the formation of clathrin-coated pits that are 
100 to 200 nm in size [40]. Caveolae are 50- to 80-nm flask-shaped plasma membrane invaginations 
found in many cell types and are marked by the presence of a member of the caveolin protein family [41]. 
The mechanisms that govern clathrin-caveolae independent endocytosis remain poorly understood. It 
is assumed that THP-1 cells take up NPs via phagocytosis. However, the entry of NPs into the cells 
depends upon the size and surface properties of the NPs and the presence of appropriate cell 
membrane receptors. Thus, one possible reason for variable responses to NP exposure may be the 
differences in the uptake mechanism between cell types. 
3. Experimental Section 
3.1. Preparation of PEG-TiO2 
TiO2 NPs (Degussa Aeroxide P25: The particle size is 25 nm; The crystal rate of anatase and rutile 
of P25 is 80% anatase and 20% rutile.) was used for PEG modification. PEG-TiO2 was prepared as 
described previously [9]. The pH of comb-shaped PEG-maleic acid anhydride (PEGMA, AM1510K; 
Nihon Yushi Co., Ltd., Tokyo, Japan) in water was adjusted to 4.0 using 0.1 M NaOH. To activate the 
PEGMA carboxyl groups, 0.6 mL of 0.8 M 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide 
hydrochloride (Pierce, Rockford, IL, USA) was added and the solution was incubated at room 
temperature for 5 min. Next, 0.3 mL of 0.2 M 4-amino-salicylic acid (4ASA; Wako Jyunyaku, Osaka, 
Japan) was added and the solution was incubated at 40 °C for 16 h. Unreacted 4ASA and other small 
molecules were removed by centrifuging five times using Amicon Ultra-15 (MWCO = 3000; Millipore, 
Billerica, MA, USA) ultra-filters, according to the manufacturer’s instructions. Exchange of the solvent 
of reacted PEGMA-4ASA was carried out after vacuum drying at 25 °C and 20 hPa for 3 min, and  
5 hPa for 35 min. The concentration of PEGMA-4ASA was adjusted to 50 mg/mL using 
dimethylformamide (DMF). An acidic TiO2 solution was prepared using thermal synthesis based on 
hydrolysis of an organo-titanium compound followed by peptization. After hydrolysis of 
chlorotitanium triisopropoxide (Acros, Morris Plains, NJ, USA), peptization with HNO3 was carried 
out at 80 °C. The reactant was adjusted to a solid content of 20% (w/v) using 1.5 M HNO3. After 
ultrasonication at 200 kHz for 30 min (Midsonic 600; Kaijyo, Tokyo, Japan), particle-size distribution 
analysis was conducted, confirming the presence of TiO2 particles with a diameter of approximately 40 nm 
in the solution. The TiO2 solution (0.75 mL) was added to 10 mL of DMF, and 5 mL of 50 mg/mL 
PEGMA-4ASA in DMF was subsequently added, followed by stirring. The solution was incubated at 
130 °C for 16 h using Chemist Plaza (Shibata Kagaku, Tokyo, Japan). The reaction was carried out 
under reflux and vigorous stirring at 600 rpm. After the reaction ended, the solution was cooled to 
room temperature. Exchange of the solvent of reacted PEG-TiO2 was carried out after vacuum drying 
at 40 °C and 5 hPa for 10 min. The concentration of PEG-TiO2 was adjusted to 10 mg/mL using water. 
The aqueous PEG-TiO2 solution was purified by centrifuging five times using Amicon Ultra-15 
(MWCO = 3000; Millipore) ultra-filters according to the manufacturer’s instructions. The zeta 
potential and particle-size distributions of PEG-TiO2 were 0.196 mV and 49.6 nm, respectively, 
measured using a Zetasizer nanoZS (Malvern Instruments, UK), according to the procedures 
recommended by the manufacturer. Int. J. Mol. Sci. 2012, 13                 
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3.2. Cell Culture 
Human NCI-H292 pulmonary epithelial cells [42] and human THP-1 acute monocytic leukemia 
cells [43,44] were cultured in RPMI 1640 medium (Invitrogen, NY, USA). Human HeLa cervical 
cancer cells [45] were cultured in Minimum Essential Medium (MEM) (Invitrogen), and human 
HepG2 hepatocarcinoma cells [46,47] were maintained in Dulbecco’s Modified Eagle’s Medium 
(DMEM) (Invitrogen). All media were supplemented with 10% fetal bovine serum (Biowest, UK),  
100 U/mL penicillin, and 100 μg/mL streptomycin (Nacalai Tesque, Japan). All cells were maintained 
under 5% CO2 and 100% humidity at 37 °C and cultured in the dark to avoid activation of the titanium 
surfaces. THP-1 cells were treated with 200 nM phorbol 12-myristate 13-acetate (PMA) (Wako 
Jyunyaku) for 48 h, after which the old medium was replaced with new medium and the cells were 
exposed to NPs for either 6 h or 24 h. Cultures of NCI-H292, HeLa, and HepG2 cells that had been 
seeded 24 h prior were exposed to NPs for 6 h or 24 h. 
3.3. Cell Viability Test 
Cell viability was measured using a Cell Titer-Glo Luminescent Cell Viability Assay kit (Promega, 
WI, USA) according to the manufacturer’s instructions [48]. For the ATP assay, 1.0 × 10
4 NCI-H292 
cells, 5.0 × 10
4 THP-1 cells, 2.0 × 10
4 HeLa cells, and 1.0 × 10
4 HepG2 cells were seeded in each well 
of a white opaque-walled 96-well cell culture plate (Nunclone, Roskilde, Denmark). After the cells 
attained 80% confluence, they were treated with different concentrations of a suspension of PEG-TiO2, 
ranging from 0.00005% (w/v) (0.5 μg/mL) to 0.01% (w/v) (100 μg/mL) for 24 h. Each PEG-TiO2 
particle suspension was added to the cell culture medium at a volume ratio of 5:100 and cultured for 24 h. 
The cytoplasmic ATP concentration was then analyzed using a Luminescent cell viability assay reader 
(Wako Jyunyaku). 
3.4. Gene Expression Analysis 
3.4.1. PCR Array 
The PCR array is the most sensitive and reliable method of gene expression analysis. For PCR array 
analysis, 1.3 × 10
5 NCI-H292 cells/cm
2 were seeded in a culture dish and exposed to a suspension of 
PEG-TiO2 NPs at a final concentration of 0.0075% (w/v) (75 μg/mL). Following 6 h of exposure to the 
PEG-TiO2 particles, the cells were detached by mechanical dissociation and the expression of 84 genes 
that are indicative of stress and toxicity was examined using PCR array analysis as follows. Total 
cellular RNA was extracted from PEG-TiO2-exposed cells using an RNeasy Kit (Qiagen) according to 
the manufacturer’s instructions. Extracted RNA was treated with DNaseI (Takara), and 4 μg of total 
RNA was reverse-transcribed into cDNA with a random hexamer primer using the PrimeScript II 1st 
strand cDNA Synthesis System (Takara) according to the manufacturer’s protocol. PCR array analysis 
was performed using an ABI PRISM 7000 Sequence Detection System (Applied Biosystems, 
Singapore). A standard reaction was prepared in 96-well plates (SA Bioscience, Qiagen) containing 
forward and reverse primers for several genes indicative of stress and toxicity. The cDNA was diluted 
five-fold with distilled water and mixed with 2× PCR master mix according to the manufacturer’s Int. J. Mol. Sci. 2012, 13                 
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protocol. An aliquot of reaction mixture (25 μL) containing the test cDNA was then added to each 
well. The thermocycling conditions were 95 °C for 10 s followed by 40 cycles of 95 °C for 15 s and 60 
°C for 1 min. A control reaction was also performed using cDNA prepared from cells that were not 
exposed to NPs. 
3.4.2. Real-Time (RT) PCR 
For mRNA expression analysis, 1.3 × 10
5 NCI-H292 cells/cm
2, 1.9 × 10
5 THP-1 cells/cm
2,  
2.2 × 10
5 HeLa cells/cm
2, and 1.1 × 10
5 Hep G2 cells/cm
2 were seeded in cell culture dishes, and the 
cells were then exposed to a suspension of PEG-TiO2 NPs at a final concentration of 0.0075% (w/v) 
(75 μg/mL) for 6 h or 24 h. Following exposure, cells were detached by mechanical dissociation and 
subjected to gene expression analysis. The expression of marker genes was determined using 
quantitative real-time PCR (RT-PCR) as follows. Total cellular RNA was extracted from   
titania-exposed cells using an RNeasy Kit (Qiagen) according to the manufacturer’s instructions. 
Extracted RNA was treated with DNaseI (Takara), and 2 μg of total RNA was reverse-transcribed into 
cDNA with a random hexamer primer using the PrimeScript II 1st strand cDNA Synthesis System 
(Takara) according to the manufacturer’s protocol. Real-time PCR was performed using an ABI 
PRISM 7000 Sequence Detection System (Applied Biosystems). A standard reaction was prepared in 
96-well plates (Micro Amp, Applied Biosystems). The reaction mixture was composed of 10 μL of 
SYBR Premix Ex Taq II (Takara), 10 pmol each of the forward and reverse primers, 2 μL of cDNA, 
and distilled water to a final volume of 20 μL. The thermocycling conditions were 95 °C for 30 s, 
followed by 40 cycles of 95 °C for 5 s and 60 °C for 34 s. Normalization of the data was performed 
using the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an endogenous 
control in the same reaction as the gene of interest [49]. The primers used in this study were as 
follows: for GAPDH, forward primer 5'-CCCCCACCACACTGAATCTC-3' and reverse primer   
5'-GCCCCTCCCCTCTTCAAG-3'; for heme oxygenase 1 (HMOX-1), forward primer   
5'-GGGTGATAGAAGAGGCCAAGA-3' and reverse primer 5'-AGCTCCTGCAACTCCTCAAA-3'; 
for IL-6, forward primer 5'-TGAGTACAAAAGTCCTGA-3' and reverse primer 5'-TCTGTGCCT 
GCAGCTTCGT-3'; for granulocyte-macrophage colony stimulating factor 2 (CSF-2), forward primer 
5'-TCTCAGAAATGTTTGACCTCCA-3' and reverse primer 5'-GCCCTTGAGC TTGGTGAG-3'. 
3.5. Statistical Analysis 
Data were expressed as the mean ± SD, (n ≥ 3). The data were analyzed using Student t test to 
evaluate the significance of differences between the treated groups and control groups. 
4. Conclusions 
Our previous results indicated that TiO2 NPs induce inflammatory and heat shock responses in 
cells. In order to minimize these responses, we conjugated TiO2 NPs with PEG to prevent aggregation. 
The cytotoxic effects of PEG-TiO2 NPs on NCI-H292 cells were less severe than those produced by 
TiO2 aggregates. However, PEG-TiO2 NPs did not produce any cytotoxicity in THP-1, HeLa, or 
HepG2 cells. Analysis of mRNA expression indicated that the expression of particular biomarkers Int. J. Mol. Sci. 2012, 13                 
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depends upon the cell type. Our results showed that modification of TiO2 NPs with PEG reduces their 
cytotoxicity and reduces the induction of genes associated with stress and toxicity. 
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